Compounds > levofloxacin
Page last updated: 2024-09-04

levofloxacin and eravacycline

levofloxacin has been researched along with eravacycline in 3 studies

Compound Research Comparison

Studies
(levofloxacin)		Trials
(levofloxacin)		Recent Studies (post-2010)
(levofloxacin)		Studies
(eravacycline)		Trials
(eravacycline)		Recent Studies (post-2010) (eravacycline)
4,3465812,20995393

Protein Interaction Comparison

ProteinTaxonomylevofloxacin (IC50)eravacycline (IC50)
30S ribosomal protein S6Escherichia coli K-120.62
30S ribosomal protein S7Escherichia coli K-120.62
50S ribosomal protein L15Escherichia coli K-120.62
50S ribosomal protein L10Escherichia coli K-120.62
50S ribosomal protein L11Escherichia coli K-120.62
50S ribosomal protein L7/L12Escherichia coli K-120.62
50S ribosomal protein L19Escherichia coli K-120.62
50S ribosomal protein L1Escherichia coli K-120.62
50S ribosomal protein L20Escherichia coli K-120.62
50S ribosomal protein L27Escherichia coli K-120.62
50S ribosomal protein L28Escherichia coli K-120.62
50S ribosomal protein L29Escherichia coli K-120.62
50S ribosomal protein L31Escherichia coli K-120.62
50S ribosomal protein L31 type BEscherichia coli K-120.62
50S ribosomal protein L32Escherichia coli K-120.62
50S ribosomal protein L33Escherichia coli K-120.62
50S ribosomal protein L34Escherichia coli K-120.62
50S ribosomal protein L35Escherichia coli K-120.62
50S ribosomal protein L36Escherichia coli K-120.62
30S ribosomal protein S10Escherichia coli K-120.62
30S ribosomal protein S11Escherichia coli K-120.62
30S ribosomal protein S12Escherichia coli K-120.62
30S ribosomal protein S13Escherichia coli K-120.62
30S ribosomal protein S16Escherichia coli K-120.62
30S ribosomal protein S18Escherichia coli K-120.62
30S ribosomal protein S19Escherichia coli K-120.62
30S ribosomal protein S20Escherichia coli K-120.62
30S ribosomal protein S2Escherichia coli K-120.62
30S ribosomal protein S3Escherichia coli K-120.62
30S ribosomal protein S4Escherichia coli K-120.62
30S ribosomal protein S5Escherichia coli K-120.62
30S ribosomal protein S8Escherichia coli K-120.62
30S ribosomal protein S9Escherichia coli K-120.62
50S ribosomal protein L13Escherichia coli K-120.62
50S ribosomal protein L14Escherichia coli K-120.62
50S ribosomal protein L16Escherichia coli K-120.62
50S ribosomal protein L23Escherichia coli K-120.62
30S ribosomal protein S15Escherichia coli K-120.62
50S ribosomal protein L17Escherichia coli K-120.62
50S ribosomal protein L21Escherichia coli K-120.62
50S ribosomal protein L30Escherichia coli K-120.62
50S ribosomal protein L6Escherichia coli K-120.62
30S ribosomal protein S14Escherichia coli K-120.62
30S ribosomal protein S17Escherichia coli K-120.62
30S ribosomal protein S1Escherichia coli K-120.62
50S ribosomal protein L18Escherichia coli K-120.62
50S ribosomal protein L2Escherichia coli K-120.62
50S ribosomal protein L3Escherichia coli K-120.62
50S ribosomal protein L24Escherichia coli K-120.62
50S ribosomal protein L4Escherichia coli K-120.62
50S ribosomal protein L22Escherichia coli K-120.62
50S ribosomal protein L5Escherichia coli K-120.62
30S ribosomal protein S21Escherichia coli K-120.62
50S ribosomal protein L25Escherichia coli K-120.62
50S ribosomal protein L36 2Escherichia coli K-120.62

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Achorn, C; Chen, CL; Clark, RB; Deng, Y; Fyfe, C; Grossman, TH; He, M; Hogan, PC; Hunt, DK; O'Brien, WJ; Plamondon, L; Rönn, M; Sutcliffe, JA; Xiao, XY; Zhu, Z1
Steenbergen, J; Tanaka, SK; Villano, S1
Grossman, TH; Kerstein, KO; O'Brien, W; Sutcliffe, JA1

Reviews

1 review(s) available for levofloxacin and eravacycline

ArticleYear
Discovery, pharmacology, and clinical profile of omadacycline, a novel aminomethylcycline antibiotic.
    Bioorganic & medicinal chemistry, 2016, 12-15, Volume: 24, Issue:24

    Topics: Anti-Bacterial Agents; Bacteria; Dose-Response Relationship, Drug; Drug Discovery; Humans; Microbial Sensitivity Tests; Molecular Conformation; Tetracyclines

2016

Other Studies

2 other study(ies) available for levofloxacin and eravacycline

ArticleYear
Fluorocyclines. 2. Optimization of the C-9 side-chain for antibacterial activity and oral efficacy.
    Journal of medicinal chemistry, 2012, Jan-26, Volume: 55, Issue:2

    Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Biological Availability; Cyclophosphamide; Drug Resistance, Multiple, Bacterial; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Lung; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Neutropenia; Rats; Rats, Sprague-Dawley; Respiratory Tract Infections; Ribosomes; Sepsis; Stereoisomerism; Structure-Activity Relationship; Tetracycline Resistance; Tetracyclines

2012
Eravacycline (TP-434) is active in vitro against biofilms formed by uropathogenic Escherichia coli.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:4

    Topics: Anti-Bacterial Agents; Biofilms; Colistin; Colony Count, Microbial; Escherichia coli Infections; Gentamicins; Humans; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Tetracyclines; Thienamycins; Urinary Tract Infections; Uropathogenic Escherichia coli

2015